JP2011507919A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507919A5 JP2011507919A5 JP2010540056A JP2010540056A JP2011507919A5 JP 2011507919 A5 JP2011507919 A5 JP 2011507919A5 JP 2010540056 A JP2010540056 A JP 2010540056A JP 2010540056 A JP2010540056 A JP 2010540056A JP 2011507919 A5 JP2011507919 A5 JP 2011507919A5
- Authority
- JP
- Japan
- Prior art keywords
- fix
- water
- ser
- hydrophilic polymer
- soluble hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010076282 Factor IX Proteins 0.000 claims 40
- 102100022641 Coagulation factor IX Human genes 0.000 claims 39
- 229960004222 factor ix Drugs 0.000 claims 35
- 229920001477 hydrophilic polymer Polymers 0.000 claims 16
- 238000000034 method Methods 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 7
- 229920001612 Hydroxyethyl starch Polymers 0.000 claims 6
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 229940050526 hydroxyethylstarch Drugs 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 229920002307 Dextran Polymers 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000031169 hemorrhagic disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000009429 hemophilia B Diseases 0.000 claims 1
- 229960002885 histidine Drugs 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US926307P | 2007-12-27 | 2007-12-27 | |
| PCT/EP2008/010925 WO2009083187A1 (en) | 2007-12-27 | 2008-12-19 | Chemically modified factor ix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507919A JP2011507919A (ja) | 2011-03-10 |
| JP2011507919A5 true JP2011507919A5 (enExample) | 2012-02-09 |
Family
ID=40344940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010540056A Pending JP2011507919A (ja) | 2007-12-27 | 2008-12-19 | 修飾第ｉｘ因子 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090176708A1 (enExample) |
| EP (4) | EP2568043A1 (enExample) |
| JP (1) | JP2011507919A (enExample) |
| KR (1) | KR20100110799A (enExample) |
| CN (1) | CN101952422A (enExample) |
| AU (1) | AU2008342260B2 (enExample) |
| CA (1) | CA2709960A1 (enExample) |
| IL (1) | IL206095A0 (enExample) |
| NZ (3) | NZ603997A (enExample) |
| RU (1) | RU2010131189A (enExample) |
| WO (1) | WO2009083187A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2353588B1 (en) | 2010-01-21 | 2015-04-15 | Agricultural Technology Research Institute | A sustained release preparation of factor IX |
| TWI788044B (zh) | 2013-03-15 | 2022-12-21 | 美商百歐維拉提夫治療公司 | 因子ｉｘ多肽調配物 |
| AR099340A1 (es) * | 2014-02-12 | 2016-07-13 | Novo Nordisk As | Conjugados del factor de coagulación ix |
| US10772942B2 (en) | 2014-03-24 | 2020-09-15 | Bioverativ Therapeutics Inc. | Lyophilized factor IX formulations |
| US20220378840A1 (en) * | 2019-11-29 | 2022-12-01 | Rutgers, The State University Of New Jersey | Compositions, kits and methods for storage of blood products and methods of use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS538750B2 (enExample) | 1971-08-18 | 1978-03-31 | ||
| AT348548B (de) | 1977-04-08 | 1979-02-26 | Laevosan Gmbh & Co Kg | Verfahren zur herstellung von alsblutplasma- expander geeignerter hydroxyaethylstaerke |
| US5614500A (en) | 1983-03-04 | 1997-03-25 | The Scripps Research Institute | Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
| DE3313600A1 (de) * | 1983-04-14 | 1984-10-18 | Laevosan-Gesellschaft mbH & Co. KG, Linz | Plasmastreckmittel auf staerkebasis und verfahren zu ihrer herstellung |
| DE19975071I2 (de) | 1989-06-16 | 2000-02-03 | Fresenius Ag | Hydroxyethylstaerke als Plasmaexpander Verfahren zu ihrer Herstellung und Verwendung als kolloidales Plasmaersatzmittel |
| FR2702160B1 (fr) | 1993-03-02 | 1995-06-02 | Biovecteurs As | Vecteurs particulaires synthétiques et procédé de préparation. |
| DE4310974C2 (de) * | 1993-04-03 | 1996-08-01 | Fresenius Ag | Verwendung von Hydroxyethylstärke zur Verbesserung der Mikrozirkulation |
| FR2704145B1 (fr) | 1993-04-21 | 1995-07-21 | Pasteur Institut | Vecteur particulaire et composition pharmaceutique le contenant. |
| US5621039A (en) * | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
| FR2723849B1 (fr) | 1994-08-31 | 1997-04-11 | Biovector Therapeutics Sa | Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique |
| EP0973544B1 (de) * | 1997-04-08 | 2001-06-27 | Baxter Aktiengesellschaft | Immuntolerante prothrombinkomplex-präparation |
| US7179617B2 (en) * | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
| EP1620118B1 (en) | 2003-04-08 | 2014-06-18 | Yeda Research And Development Co., Ltd. | Reversible pegylated drugs |
| WO2005014655A2 (en) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| EP1694315A4 (en) * | 2003-12-03 | 2009-10-28 | Novo Nordisk As | FACTOR IX GLYCOPEGYL |
| US20060040856A1 (en) * | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| KR101215226B1 (ko) | 2004-03-01 | 2012-12-26 | 베. 브라운 멜중엔 악티엔게젤샤프트 | 하이드록시에틸전분 |
| WO2005092928A1 (en) * | 2004-03-11 | 2005-10-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| WO2006018204A1 (en) * | 2004-08-17 | 2006-02-23 | Zlb Behring Gmbh | Modified vitamin k dependent polypeptides |
| JP2008532966A (ja) * | 2005-03-11 | 2008-08-21 | フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 不活性出発物質からの生理活性糖タンパク質の生成 |
| WO2007101681A1 (en) | 2006-03-07 | 2007-09-13 | Baxter International Inc | Highly phosphorylated and sulfated recombinant factor ix |
| CN101454267B (zh) | 2006-03-29 | 2012-09-26 | 帝斯曼知识产权资产管理有限公司 | 姜黄素的合成 |
| TW200804416A (en) * | 2006-06-19 | 2008-01-16 | Nautilus Technology Llc | Modified coagulation factor IX polypeptides and use thereof for treatment |
| EP2155865B1 (en) * | 2007-06-15 | 2014-09-17 | National Research Council Of Canada | Engineered versions of polysialyltransferases with enhanced enzymatic properties |
-
2008
- 2008-12-19 NZ NZ603997A patent/NZ603997A/xx not_active IP Right Cessation
- 2008-12-19 EP EP12008216A patent/EP2568043A1/en not_active Withdrawn
- 2008-12-19 EP EP12008214A patent/EP2568041A1/en not_active Withdrawn
- 2008-12-19 CA CA2709960A patent/CA2709960A1/en not_active Abandoned
- 2008-12-19 NZ NZ598193A patent/NZ598193A/xx not_active IP Right Cessation
- 2008-12-19 CN CN2008801232530A patent/CN101952422A/zh active Pending
- 2008-12-19 RU RU2010131189/10A patent/RU2010131189A/ru not_active Application Discontinuation
- 2008-12-19 EP EP12008215A patent/EP2568042A1/en not_active Withdrawn
- 2008-12-19 EP EP08868384A patent/EP2247723A1/en not_active Withdrawn
- 2008-12-19 US US12/339,619 patent/US20090176708A1/en not_active Abandoned
- 2008-12-19 KR KR1020107014071A patent/KR20100110799A/ko not_active Ceased
- 2008-12-19 NZ NZ585835A patent/NZ585835A/en not_active IP Right Cessation
- 2008-12-19 AU AU2008342260A patent/AU2008342260B2/en not_active Expired - Fee Related
- 2008-12-19 WO PCT/EP2008/010925 patent/WO2009083187A1/en not_active Ceased
- 2008-12-19 JP JP2010540056A patent/JP2011507919A/ja active Pending
-
2010
- 2010-05-31 IL IL206095A patent/IL206095A0/en unknown
-
2011
- 2011-12-29 US US13/339,823 patent/US20120177625A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7627498B2 (ja) | 生物医学的応用のための制御可能な自己アニーリング型ミクロゲル粒子 | |
| Zhang et al. | Hydrogels based on pH-responsive reversible carbon–nitrogen double-bond linkages for biomedical applications | |
| Sahajpal et al. | Dynamic protein and polypeptide hydrogels based on Schiff base co-assembly for biomedicine | |
| Ding et al. | Weak bond-based injectable and stimuli responsive hydrogels for biomedical applications | |
| Wickremasinghe et al. | Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release | |
| EP1501548B1 (en) | Chemically activated carboxypolysaccharides and uses | |
| JP2006513992A5 (enExample) | ||
| JP2012126750A5 (enExample) | ||
| US20130231287A1 (en) | Pegylated albumin polymers and uses thereof | |
| CN111440253A (zh) | 立方形环糊精骨架-rgd组合物及其制备方法 | |
| Wickremasinghe et al. | Controlled angiogenesis in peptide nanofiber composite hydrogels | |
| JP2008525491A5 (enExample) | ||
| JP2011507919A5 (enExample) | ||
| US20180000949A1 (en) | Orally Active, Cell-Penetrating Homing Peptide and Methods of Using Same | |
| TWI243057B (en) | Formulations for protection of peg-interferon alpha conjugates | |
| KR20220130824A (ko) | 전기방사되는 중합체 기반 천연 조성물, 및 그 제조 방법 | |
| CN104105480A (zh) | 聚合药物递送材料、其制造方法及递送药物递送组合物的方法 | |
| KR20220134781A (ko) | 천연 중합체에 기반한 패치 제품 | |
| JP5698296B2 (ja) | 静脈内投与による有効成分制御放出のための生体適合性を有するアルギン酸微粒子組成物 | |
| RU2010131189A (ru) | Химически модифицированный фактор iх | |
| ES2336380T3 (es) | Formulacion farmaceuticas que comprenden dextrano con un peso molecular de 1,0-100 kda y procedimiento para su preparacion. | |
| Liu et al. | Matrix metalloproteinase-triggered self-assembling peptides for biomedical applications | |
| TW201521761A (zh) | 重組體ｆｖｉｉｉ調配物 | |
| CN112755197B (zh) | 一种环糊精药物包合物及其制备方法和应用 | |
| EP3975927B1 (en) | Mucoadhesive microgel compositions and methods for using the same |